Fosrenol will be a new phosphate binder for dialysis patients
December 2004
Fosrenol will be a new phosphate binder for dialysis patients.
It's an alternative to PhosLo, Renagel, AlternaGel, etc.
Phosphate increases in the blood as kidney function declines. This leads to hypocalcemia and secondary hyperparathyroidism.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote